+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast to 2030- Product Image
Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast to 2030- Product Image
Sale

Livestock Medicine Market by Product Type, Disease Type, Animal Type, Formulation, Route of Administration, End Users - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715776
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The livestock medicine market is undergoing rapid transformation as global food security challenges, shifting regulations, and technological advancements drive demand for improved animal health solutions. Senior executives must navigate a landscape shaped by evolving therapeutic options, increased regulatory scrutiny, and dynamic supply chain pressures.

Market Snapshot: Livestock Medicine Market Growth and Opportunity

The Livestock Medicine Market grew from USD 19.56 billion in 2024 to USD 20.56 billion in 2025. It is expected to continue growing at a CAGR of 5.27%, reaching USD 26.63 billion by 2030. Robust expansion is fueled by demand for enhanced disease management, innovation in animal therapeutics, and intensifying regulatory expectations worldwide. This trajectory indicates considerable market momentum for companies developing targeted, compliant solutions in livestock pharmaceuticals and biologics.

Scope & Segmentation

  • Product Categories: Anti-inflammatory agents, antibiotics (cephalosporins, penicillins, tetracyclines), antiparasitic agents (ectoparasiticides, endoparasiticides), feed additives (prebiotics, probiotics), hormones (growth and reproductive), and vaccines (inactivated, live attenuated, subunit).
  • Disease Types: Infectious, metabolic, nutritional deficiency, parasitic, and reproductive diseases.
  • Livestock Animal Types: Aquaculture, cattle, goats, poultry, sheep, swine.
  • Formulations: Capsules, gels, liquids, powders, tablets.
  • Routes of Administration: Inhalation, injectable (intramuscular, intravenous), oral (liquids, tablets), topical (creams, patches).
  • End Users: Livestock farmers, veterinary clinics, veterinary hospitals.
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with locations such as UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and additional markets).
  • Companies Profiled: Global participants including Zoetis Inc., Boehringer Ingelheim International GmbH, Merck KGaA, Virbac SA, Elanco Animal Health Inc., Ceva Sante Animale, Vetoquinol S.A., Neogen Corporation, and more.

Key Takeaways for Senior Decision-Makers

  • Adoption of precision delivery systems and digital herd health management platforms enhances therapeutic outcomes and preventive care across diverse livestock operations.
  • Regulatory evolution is fostering closer collaboration between public and private stakeholders, impacting product development timelines and compliance frameworks for livestock pharmaceuticals.
  • Sustainability initiatives are reducing antibiotic usage while sparking investment in next-generation vaccines and alternative medicines that meet rigorous safety demands.
  • Competitive strategies increasingly hinge on technology integration, regional production hubs, and ESG-aligned portfolio diversification to meet shifting market and regulatory requirements.
  • Veterinary service models are evolving with the rise of telemedicine and remote monitoring solutions, opening new channels for product distribution and real-time data collection.

Tariff Impact on Global Supply Chains

Recent US tariffs on select livestock medications and active pharmaceutical ingredients have disrupted sourcing strategies and prompted manufacturers to optimize margin structures. These trade measures have accelerated the push for regional supply chain diversification, local manufacturing expansion, and strategic bilateral agreements to minimize exposure to tariff-related cost volatility.

Methodology & Data Sources

This analysis is grounded in comprehensive secondary research, validated by qualitative interviews with senior executives and subject-matter experts. Findings are cross-checked using public regulatory documents, clinical trial data, and company disclosures. Quantitative analyses undergo statistical audits and data triangulation to ensure reliability and consistency.

Why This Report Matters

  • Facilitates informed, data-driven decision-making by providing granular analysis of livestock medicine product channels, disease targeting, and regional market trends.
  • Supports strategic portfolio planning via detailed segmentation by therapeutic area, delivery technology, and end-user profiles.
  • Equips senior leaders to anticipate and adapt to regulatory changes, ESG expectations, and emergent market risks affecting livestock health value chains.

Conclusion

The livestock medicine industry is facing accelerated change driven by regulatory, technological, and geopolitical dynamics. Decision-makers who leverage targeted market intelligence will position their organizations to address future challenges and realize sustainable growth in animal health solutions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased government regulations and initiatives to ensure animal welfare and minimize disease spread
5.1.1.2. Growing awareness among livestock farmers about the benefits of preventive healthcare measures
5.1.1.3. Rising prevalence of livestock diseases boosting investments in veterinary pharmaceuticals
5.1.2. Restraints
5.1.2.1. Limited research funding and innovation slowing down the development of next-generation livestock drugs
5.1.3. Opportunities
5.1.3.1. Expansion of antibiotic alternatives in livestock production in response to regulatory changes
5.1.3.2. Collaboration with biotech firms to innovate groundbreaking vaccines for emerging livestock diseases
5.1.4. Challenges
5.1.4.1. Risks of disease outbreaks and biosecurity in the livestock industry
5.2. Market Segmentation Analysis
5.2.1. Product Type : Growing significance of antibiotics in preventing and managing bacterial infections among livestock populations
5.2.2. End Users: Rising role of veterinary hospitals in the implementation of precision medicine for livestock
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Livestock Medicine Market, by Product Type
6.1. Introduction
6.2. Anti-inflammatory Agents
6.3. Antibiotics
6.3.1. Cephalosporins
6.3.2. Penicillins
6.3.3. Tetracyclines
6.4. Antiparasitic Agents
6.4.1. Ectoparasiticides
6.4.2. Endoparasiticides
6.5. Feed Additives
6.5.1. Prebiotics
6.5.2. Probiotics
6.6. Hormones
6.6.1. Growth Hormones
6.6.2. Reproductive Hormones
6.7. Vaccines
6.7.1. Inactivated Vaccines
6.7.2. Live Attenuated Vaccines
6.7.3. Subunit Vaccines
7. Livestock Medicine Market, by Disease Type
7.1. Introduction
7.2. Infectious Diseases
7.3. Metabolic Diseases
7.4. Nutritional Deficiency Diseases
7.5. Parasitic Diseases
7.6. Reproductive Diseases
8. Livestock Medicine Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.3. Cattle
8.4. Goats
8.5. Poultry
8.6. Sheep
8.7. Swine
9. Livestock Medicine Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Gels
9.4. Liquids
9.5. Powders
9.6. Tablets
10. Livestock Medicine Market, by Route of Administration
10.1. Introduction
10.2. Inhalation
10.3. Injectable
10.3.1. Intramuscular
10.3.2. Intravenous
10.4. Oral
10.4.1. Liquids
10.4.2. Tablets
10.5. Topical
10.5.1. Creams
10.5.2. Patches
11. Livestock Medicine Market, by End Users
11.1. Introduction
11.2. Livestock Farmers
11.3. Veterinary Clinics
11.4. Veterinary Hospitals
12. Americas Livestock Medicine Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Livestock Medicine Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Livestock Medicine Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. Phibro Animal Health Corporation completes acquisition of Zoetis’ medicated feed additive product portfolio
15.3.2. Fischer MV partners with BAV to launch advanced vaccines in India
15.3.3. Virbac's strategic acquisition of Sasaeah strengthens its position in Japan's livestock vaccine market
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. LIVESTOCK MEDICINE MARKET MULTI-CURRENCY
FIGURE 2. LIVESTOCK MEDICINE MARKET MULTI-LANGUAGE
FIGURE 3. LIVESTOCK MEDICINE MARKET RESEARCH PROCESS
FIGURE 4. LIVESTOCK MEDICINE MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. LIVESTOCK MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. LIVESTOCK MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LIVESTOCK MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. LIVESTOCK MEDICINE MARKET DYNAMICS
TABLE 7. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTI-INFLAMMATORY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY NUTRITIONAL DEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY REPRODUCTIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GOATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY LIVESTOCK FARMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL LIVESTOCK MEDICINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 111. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 113. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 114. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 115. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 116. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 117. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 122. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 123. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 124. CANADA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 128. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 129. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 130. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 137. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 138. MEXICO LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES LIVESTOCK MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC LIVESTOCK MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 169. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 183. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 185. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 186. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 187. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 188. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 189. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 190. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 191. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 194. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 195. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 196. CHINA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 197. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 199. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 200. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 201. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 202. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 203. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 205. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 206. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 208. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 209. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 210. INDIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 211. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 213. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 214. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 225. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 227. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 228. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 229. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 230. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 231. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 232. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 236. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 237. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 238. JAPAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 239. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 241. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 242. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 243. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 244. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 272. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 273. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 274. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 285. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 287. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 288. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 291. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 292. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 293. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 295. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 297. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 298. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 299. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 300. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 301. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 302. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 303. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 306. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 307. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 308. TAIWAN LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 309. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 311. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 312. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 313. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 314. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 315. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 316. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 317. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 321. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 323. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 325. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 326. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 327. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 328. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 329. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 330. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 331. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 332. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 333. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 334. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 335. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 336. VIETNAM LIVESTOCK MEDICINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIBIOTICS, 2018-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANTIPARASITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY HORMONES, 2018-2030 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 347. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 348. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 349. EUROPE, MIDDLE EAST & AFRICA LIVESTOCK MEDICINE MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 350. EUROPE, MIDDLE EAST & AFRICA LIVE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Livestock Medicine market report include:
  • Anicon Labor GmbH by SAN Group GmbH
  • AniCura Group by Mars Petcare
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Calier Laboratories S.A.
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • HESTER BIOSCIENCES LIMITED
  • HIPRA S.A.
  • Indian Immunologicals Ltd.
  • Koninklijke DSM N.V.
  • Merck KGaA
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Parnell Pharmaceuticals Holdings Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Vetpharma Animal Health S.L.
  • Virbac SA
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.63 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Live Animals Market Report 2025 - Product Image

Live Animals Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Asia-Pacific Livestock Insurance Market, By Country, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Asia-Pacific Livestock Insurance Market, By Country, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 132 Pages
  • Asia Pacific
From
Livestock Insurance Market by Animal Type, Insurance Type, Coverage Type, Distribution Channel, Provider, Premium Type - Global Forecast to 2030 - Product Image

Livestock Insurance Market by Animal Type, Insurance Type, Coverage Type, Distribution Channel, Provider, Premium Type - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Veterinary Medicine Market by Animal Type, Product Type, Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast to 2030 - Product Image

Veterinary Medicine Market by Animal Type, Product Type, Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Traditional Chinese Medicine Formulations for Veterinary Use Market by Animal Type, Dosage Form, Distribution Channel, End User, Application Route - Global Forecast to 2030 - Product Image

Traditional Chinese Medicine Formulations for Veterinary Use Market by Animal Type, Dosage Form, Distribution Channel, End User, Application Route - Global Forecast to 2030

  • Report
  • 190 Pages
  • China, Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.